Cargando…
Cancers after HLA-matched related Bone Marrow Transplantation for Aplastic Anemia
We analyzed subsequent cancers in 329 patients with aplastic anemia given HLA-matched related marrow grafts. Median follow-up: 26 (range 1-47) years. Conditioning: cyclophosphamide ± antithymocyte globulin; graft-vs.-host disease (GVHD) prevention: methotrexate ± cyclosporine. The long follow-up and...
Autores principales: | Vo, Phuong, Onstad, Lynn, Flowers, Mary E., Storb, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738111/ https://www.ncbi.nlm.nih.gov/pubmed/34657145 http://dx.doi.org/10.1038/s41409-021-01498-1 |
Ejemplares similares
-
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?
por: Gallo, Susanna, et al.
Publicado: (2016) -
Magnetic resonance imaging of the bone marrow after bone marrow transplantation or immunosuppressive therapy in aplastic anemia.
por: Park, J. M., et al.
Publicado: (2001) -
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
por: Kekre, Natasha, et al.
Publicado: (2017) -
Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia
por: Zhang, Le, et al.
Publicado: (2022) -
Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
por: Medinger, Michael, et al.
Publicado: (2018)